2011 | 2010 | 2009 | 2008 | |
All haemoptysis | ||||
Mortality at initial stay | 10.1 | 9.1 | 8.9 | 8.7 |
Mortality at initial stay (excluding lung cancer) | 7.1 | 6.3 | 6.3 | 5.9 |
1-year mortality rate | 23.3 | 21.7 | 21.1 | 20.6 |
Survival days | 69±97, 17 (0–109) | 72±99, 20 (0–114) | 72±98, 21 (0–115) | 72±99, 18 (0–117) |
1-year mortality rate (excluding lung cancer) | 15.7 | 14.5 | 14.5 | 13.6 |
Survival days | 68±97, 10 (0–108) | 75±104, 16.5 (0–124) | 74±101, 19 (0–124.5) | 76±104, 15 (0–134) |
3-year mortality rate | 27.2 | 26.8 | ||
Survival days | 204±278, 64 (0–317) | 209±284, 64 (0–323) | ||
3-year mortality rate (excluding lung cancer) | 20.1 | 19.2 | ||
Survival days | 243±303, 91 (0–426) | 252±310, 100 (0–432) | ||
Cryptogenic haemoptysis | ||||
Mortality at initial stay | 6.2 | 5.6 | 5.3 | 4.9 |
1-year mortality rate | 15 | 13.3 | 13.7 | 12.7 |
Survival days | 69±95, 16 (0–112) | 72±101, 17 (0–120) | 78±101, 27.5 (0–137) | 83±107, 24.5 (0–146) |
3-year mortality rate | 18.9 | 17.9 | ||
Survival days | 243±300, 102 (0–417) | 258±310, 114 (0–435) |
Data are presented as % or mean±sd and median (interquartile range). Mortality rates describe in-hospital mortality only.